Opsoclonus myoclonus ataxia syndrome, ovarian teratoma and anti-NMDAR antibody: an ‘unresolved’ mystery
Open Access
- 23 June 2023
- journal article
- research article
- Published by BMJ in BMJ Neurology Open
- Vol. 5 (1) , e000414
Abstract
Background Opsoclonus–myoclonus–ataxia syndrome (OMAS) is characterised by the combination of opsoclonus and arrhythmic action myoclonus with axial ataxia and dysarthria. In adults, a majority are paraneoplastic secondary to solid organ tumours and could harbour antibodies against intracellular epitopes; however, certain proportions have detectable antibodies to various neuronal cell surface antigens. Anti-N-methyl-D-aspartate (NMDAR) antibodies and ovarian teratomas have been implicated in OMAS. Methods Report of two cases and review of literature. Results Two middle-aged women presented with subacute-onset, rapidly progressive OMAS and behavioural changes consistent with psychosis. The first patient had detectable antibodies to NMDAR in the cerebrospinal fluid (CSF) alone. Evaluation for ovarian teratoma was negative. The second patient had no detectable antibodies in serum or CSF; however, she had an underlying ovarian teratoma. Patient A was treated with pulse steroids, therapeutic plasma exchange (TPE) followed by bortezomib (BOR) and dexamethasone, while patient B was treated with steroids, TPE followed by surgical resection of ovarian teratoma. Both patients had favourable outcomes and were asymptomatic at the 6 monthly follow-up. Conclusions With coexistent neuropsychiatric manifestations, OMAS can be considered a distinct entity of autoimmune encephalitis, pathogenesis being immune activation against known/unknown neuronal cell surface antigens. The observation of absence of anti-NMDAR antibody in patients with teratoma-associated OMAS and vice versa is intriguing. Further research on the potential role of ovarian teratoma in evoking neuronal autoimmunity and its targets is required. The management challenge in both cases including the potential use of BOR has been highlighted.Keywords
This publication has 23 references indexed in Scilit:
- Immunopathological Significance of Ovarian Teratoma in Patients with Anti-N-Methyl-D-Aspartate Receptor EncephalitisEuropean Neurology, 2013
- A novel treatment‐responsive encephalitis with frequent opsoclonus and teratomaAnnals of Neurology, 2013
- Ovarian Teratoma Associated With Anti-N-Methyl D-Aspartate Receptor EncephalitisInternational Journal of Gynecological Pathology, 2012
- N-methyl-D-aspartate Receptor Autoimmune Encephalitis Presenting With Opsoclonus-MyoclonusArchives of Neurology, 2011
- The opsoclonus–myoclonus syndromePractical Neurology, 2011
- B cell depletion therapy for new‐onset opsoclonus‐myoclonusMovement Disorders, 2010
- Opsoclonus-Myoclonus Syndrome in Anti-N-Methyl-D-Aspartate Receptor EncephalitisArchives of Neurology, 2010
- Analysis of antibodies to neuronal surface antigens in adult opsoclonus–myoclonusJournal of Neuroimmunology, 2008
- B- and T-cell markers in opsoclonus–myoclonus syndromeNeurology, 2004
- A hypothetical explanation of saccadic oscillationsAnnals of Neurology, 1979